Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/102076
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorVan Ryswyk, E.en
dc.contributor.authorMiddleton, P.en
dc.contributor.authorHague, W.en
dc.contributor.authorCrowther, C.en
dc.date.issued2015en
dc.identifier.citationDiabetic Medicine, 2015; 32(10):1368-1376en
dc.identifier.issn0742-3071en
dc.identifier.issn1464-5491en
dc.identifier.urihttp://hdl.handle.net/2440/102076-
dc.descriptionFirst published: 22 April 2015en
dc.description.abstractAims: This parallel group randomized controlled trial assessed whether an SMS reminder system for women, after gestational diabetes, would increase their attendance for an oral glucose tolerance test (OGTT) by six months postpartum. Methods: Women were eligible for inclusion if they were diagnosed with gestational diabetes in their recent pregnancy, had a mobile phone and normal blood glucose profile prior to postnatal discharge from the Women's and Children's Hospital, Adelaide. A computer-generated random number sequence and telephone randomization were used. Two hundred and seventy-six women were randomized. Women in the six-week group (n = 140) were sent a text reminder to attend for an OGTT at six weeks postpartum, with further reminders at three and six months if required. Women in the control group (n = 136) received one text reminder at six months postpartum. Blinding was not feasible. The primary outcome was OGTT attendance within six months postpartum. Results: Women in the six-week group did not increase their attendance for an OGTT within six months postpartum compared with women in the control group, 104 (77.6% of 134) versus 103 (76.8% of 134), relative risk (RR) 1.01, 95% confidence interval (CI) 0.89-1.15. Conclusions: The SMS reminder system did not increase postpartum OGTT, fasting plasma glucose or HbA1c completion, although high rates of test completion were measured in both groups. Further research is required into factors influencing attendance for postpartum testing from the perspective of women, and into optimal counselling relating to Type 2 diabetes risk in the postpartum period for increasing postpartum glucose testing rates.en
dc.description.statementofresponsibilityE. M. Van Ryswyk, P. F. Middleton, W. M. Hague and C. A. Crowtheren
dc.language.isoenen
dc.publisherWileyen
dc.rights© 2015 The Authors. Diabetic Medicine. © 2015 Diabetes UK.en
dc.subjectDiabetes, Gestationalen
dc.titlePostpartum SMS reminders to women who have experienced gestational diabetes to test for Type 2 diabetes: the DIAMIND randomized trialen
dc.typeJournal articleen
dc.identifier.rmid0030026153en
dc.identifier.doi10.1111/dme.12769en
dc.identifier.pubid182731-
pubs.library.collectionPaediatrics publicationsen
pubs.library.teamDS03en
pubs.verification-statusVerifieden
pubs.publication-statusPublisheden
dc.identifier.orcidMiddleton, P. [0000-0002-8573-338X]en
dc.identifier.orcidHague, W. [0000-0002-5355-2955]en
Appears in Collections:Paediatrics publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.